)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Caplin Point Laboratories
Caplin Point Laboratories (524742) investor relations material
Caplin Point Laboratories Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary12 Nov, 2026
Executive summary
H1 FY27 total revenue reached ₹1,307.04 crore, up 19.1% YoY; EBITDA was ₹503.54 crore, up 19.8%, and PAT was ₹361.42 crore, up 16.2%.
H1 priorities include expanding regulated-market sales and CSU, strengthening manufacturing and API integration, and growing Latin American distribution through asset-light and asset-heavy models.
Financial highlights
Q2 FY27 revenue from operations was ₹629.84 crore, up 17.9% YoY; EBITDA rose 16.8% to ₹256.5 crore, PBT 15.8% to ₹232.83 crore, and PAT 13.8% to ₹182.35 crore.
H1 FY27 gross profit was ₹756.33 crore, up 18.4% YoY; EBIT increased 18.8% to ₹458.43 crore.
H1 US business revenue was ₹271 crore, up 22.8% YoY; Caplin Steriles USA sales exceeded FY26 sales.
Standalone H1 revenue was ₹444.83 crore, PBT ₹317.64 crore and PAT ₹250.89 crore, versus ₹357.75 crore, ₹241.46 crore and ₹188.48 crore in H1 FY26.
Outlook and guidance
CSU expects FY27 revenue and profitability to double; management is targeting 20%-25% U.S. business growth, with 10 additional U.S. launches planned for FY28.
More than 60 products are planned for filing in non-U.S. markets over 18 months; meaningful revenue is expected in FY27/FY28.
COL-II construction is targeted for completion by August 2027; meaningful revenue is expected in FY28-29 and beyond, following transfers, studies, filings and inspection.
Amaris Clinical expansion to 120 beds is expected by FY27-end; oncology API facility completion is targeted for CY27, with DMF filings planned afterward.
Mexico liquid-orals and IV-fluid manufacturing is planned for export into Central America; facility completion may take 2-3 years.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Caplin Point Laboratories
- Record revenue and profit growth, strong US expansion, and robust cash reserves with zero debt.524742
Q4 23/24 - Q1 FY27 revenue up 20.7% YoY to ₹644 Crores, PAT up 18.8% to ₹179 Crores, strong margins.524742Q1 26/27
- FY26 revenue up 13.2% and PAT up 20.1%, with robust cash reserves and no debt.524742Q4 25/26
- Double-digit growth, strong margins, and major expansion in US and Latin America.524742Q3 25/26
- H1 FY26 revenue and profit surged, margins improved, and major capex is underway.524742Q2 25/26
- Q1 FY25 delivered double-digit growth, margin expansion, and strong cash reserves, led by US and LATAM.524742Q1 24/25
- Q2 FY25 revenue up 18% YoY, PAT over ₹250 Cr, US revenue up 41%, strong margins, robust expansion.524742Q2 24/25
- Q3 FY25 revenue up 15.8% YoY, with strong margins and cash reserves fueling global expansion.524742Q3 24/25
- FY25 revenue up 15.5% YoY to ₹2,034 Cr, PAT up 17.3%, and free cash reserves at ₹1,180 Cr.524742Q4 24/25
Next Caplin Point Laboratories earnings date
Q3 26/274 Feb, 2027
Caplin Point Laboratories
Next Caplin Point Laboratories earnings date
Q3 26/274 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)